Search Results - Calvo-Río V

Refine Results
CSV Export
  1. 1

    Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases.

    Article | by Atienza-Mateo B; Martín-Varillas JL; Calvo-Río V; Demetrio-Pablo R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adan A; Hernández MV; Hernández-Garfella M; Valls-Pascual, Elia; Martinez-Costa, Lucia; Sellas-Fernández A; Cordero-Coma M; Díaz-Llopis M; Gallego R; García-Serrano JL; Ortego-Centeno N; Herreras JM; Fonollosa A; Garcia-Aparicio ÁM; Maíz-Alonso O; Blanco A; Torre-Salaberri I; Fernandez-Espartero C; Jovani, Vega; Peiteado D; Pato E; Cruz J; Férnandez-Cid C; Aurrecoechea E; García-Arias M; Castañeda S; Caracuel-Ruiz MA; Montilla-Morales CA; Atanes-Sandoval A; Francisco F; Insua S; González-Suárez S; Sanchez-Andrade A; Gamero F; Linares Ferrando LF; Romero-Bueno F; García-González AJ; Raquel AG; Minguez Muro E; Carrasco-Cubero C; Olive A; Prior Á; Vázquez J; Ruiz-Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernandez S; Fernandez-Carballido, Cristina; Rubio-Romero E; Pages FA; Toyos-Sáenz de Miera FJ; Gandia Martinez M; Díaz-Valle D; López Longo FJ; Nolla JM; Raya Álvarez E; Revenga Martínez M; González-López JJ; Rodríguez-Cundin P; Hernández JL; González-Gay MA; Blanco R | Published 2019 |
    Other Authors: “…Calvo-Río V…”
  2. 2

    Tocilizumab in Behcet's disease with refractory ocular and/or neurological involvement: response according to different clinical phenotypes

    Article | by Atienza-Mateo B; Beltrán E; Hernández-Garfella M; Valls Pascual E; Martínez-Costa L; Atanes A; Moriano C; Cordero-Coma M; Nolla JM; Carrasco Cubero C; Sánchez Martín J; Calvo-Río V; Demetrio R; Palmou-Fontana N; González-Gay MÁ; Blanco R | Published 2021 |
    Other Authors: “…Calvo-Río V…”
  3. 3

    Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients.

    Article | by Martín-Varillas JL; Sanchez-Bilbao L; Calvo-Río V; Adán A; Hernanz I; Gallego-Flores A; Beltran-Catalan E; Castro-Oreiro S; Fanlo P; Garcia Martos A; Torre I; Cordero-Coma M; De Dios JR; García-Aparicio Á; Hernández-Garfella M; Sánchez-Andrade A; García-Valle A; Maiz O; Miguélez R; Rodríguez-Montero S; Urruticoechea A; Veroz R; Conesa A; Fernández-Carballido C; Jovaní V; Mondejar JJ; Martínez González O; Moya Alvarado P; Romero-Yuste S; Rubio-Muñoz P; Peña-Sainz-Pardo E; Garijo-Bufort M; Demetrio-Pablo R; Hernández JL; Blanco R | Published 2022 |
    Other Authors: “…Calvo-Río V…”
  4. 4

    Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients

    Article | by Martin-Varillas, JL; Sanchez-Bilbao, L; Calvo-Rio, V; Adan, A; Hernanz, I; Gallego-Flores, A; Beltran-Catalan, E; Castro-Oreiro, S; Fanlo, P; Martos, AG; Torre, I; Cordero-Coma, M; De Dios, JR; Garcia-Aparicio, A; Hernandez-Garfella, M; Sanchez-Andrade, A; Garcia-Valle, A; Maiz, O; Miguelez, R; Rodriguez-Montero, S; Urruticoechea, A; Veroz, R; Conesa, A; Fernandez-Carballido, C; Jovani, V; Mondejar, JJ; Gonzalez, OM; Alvarado, PM; Romero-Yuste, S; Rubio-Munoz, P; Pena-Sainz-Pardo, E; Garijo-Bufort, M; Demetrio-Pablo, R; Hernandez, JL; Blanco, R | Published 2022 |
    Other Authors: “…Calvo-Rio, V…”
  5. 5

    Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients

    Article | by Martin-Varillas, JL; Sanchez-Bilbao, L; Calvo-Rio, V; Adan, A; Hernanz, I; Gallego-Flores, A; Beltran-Catalan, E; Castro-Oreiro, S; Fanlo, P; Martos, AG; Torre, I; Cordero-Coma, M; De Dios, JR; Garcia-Aparicio, A; Hernandez-Garfella, M; Sanchez-Andrade, A; Garcia-Valle, A; Maiz, O; Miguelez, R; Rodriguez-Montero, S; Urruticoechea, A; Veroz, R; Conesa, A; Fernandez-Carballido, C; Jovani, V; Mondejar, JJ; Gonzalez, OM; Alvarado, PM; Romero-Yuste, S; Rubio-Munoz, P; Pena-Sainz-Pardo, E; Garijo-Bufort, M; Demetrio-Pablo, R; Hernandez, JL; Blanco, R | Published 2022 |
    Other Authors: “…Calvo-Rio, V…”
  6. 6

    Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice.

    Article | by Calderón-Goercke M; Loricera J; Aldasoro V; Castañeda S; Villa I; Humbría A; Moriano C; Romero-Yuste S; Narváez J; Gómez-Arango C; Pérez-Pampín E; Melero R; Becerra-Fernández E; Revenga M; Álvarez-Rivas N; Galisteo C; Sivera F; Olivé-Marqués A; Álvarez Del Buergo M; Marena-Rojas L; Fernández-López C; Navarro F; Raya E; Galindez-Agirregoikoa E; Arca B; Solans-Laqué R; Conesa A; Hidalgo C; Vázquez C; Román-Ivorra JA; Lluch P; Manrique-Arija S; Vela P; De Miguel E; Torres-Martín C; Nieto JC; Ordas-Calvo C; Salgado-Pérez E; Luna-Gomez C; Toyos-Sáenz de Miera FJ; Fernández-Llanio N; García A; Larena C; Palmou-Fontana N; Calvo-Río V; Prieto-Peña D; González-Vela C; Corrales A; Varela-García M; Aurrecoechea E; Dos Santos R; García-Manzanares Á; Ortego N; Fernández S; Ortiz-Sanjuán F; Corteguera M; Hernández JL; González-Gay MÁ; Blanco R | Published 2019 |
    Other Authors: “…Calvo-Río V…”
  7. 7

    Efficacy and safety of certolizumab pegol in pregnant women with uveitis. Recommendations on the management with immunosuppressive and biologic therapies in uveitis during pregnanc...

    Article | by Prieto-Pena, D; Calderon-Goercke, M; Adan, A; Chamorro-Lopez, L; Maiz-Alonso, O; Aberasturi, JRDJ; Veroz, R; Blanco, S; Martin-Santos, JM; Navarro, F; Gallego, A; Gonzalez-Suarez, S; Conesa, A; Garcia-Valle, A; Cordero-Coma, M; Pardinas-Baron, N; Demetrio, R; Calvo-Rio, V; Martinez-Taboada, VM; Castaneda, S; Hernandez, JL; Gonzalez-Gay, MA; Blanco, R | Published 2021 |
    Other Authors: “…Calvo-Rio, V…”
  8. 8

    The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behcet's disease: results of a multicentre open-label study

    Article | by Santos-Gómez M; Calvo-Río V; Blanco R; Beltrán E; Mesquida M; Adán A; Cordero-Coma M; García-Aparicio ÁM; Valls Pascual E; Martínez-Costa L; Hernández MV; Hernandez Garfella M; González-Vela MC; Pina T; Palmou-Fontana N; Loricera J; Hernández JL; González-Gay MA | Published 2016 |
    Other Authors: “…Calvo-Río V…”
  9. 9

    Apremilast in refractory orogenital ulcers and other manifestations of Behcet's disease. A national multicentre study of 51 cases in clinical practice

    Article | by Atienza-Mateo, B; Martin-Varillas, JL; Grana, J; Espinosa, G; Moriano, C; Perez-Sandoval, T; Garcia-Armario, MD; Castellvi, I; Roman-Ivorra, JA; Olive, A; Ybanez, A; Martinez-Ferrer, A; Narvaez, J; Romero-Yuste, S; Ojeda, S; Ros, I; Loricera, J; Calvo-Rio, V; Castaneda, S; Gonzalez-Gay, MA; Blanco, R | Published 2020 |
    Other Authors: “…Calvo-Rio, V…”
  10. 10

    Macitentan in the Treatment of Digital Ulcers in Patients with Systemic Rheumatic Autoimmune Diseases: A National Multicenter Study of 42 Patients.

    Article | by Retuerto-Guerrero M; Moriano Morales C; Castellvi Barranco I; Godoy Tundido MH; Méndez Perles C; de la Puente Bujidos C; Pareja Martínez AS; Garijo Bufort M; Riancho Zarrabeitia L; Aurrecoechea Aguinaga E; González Arribas G; Vicente-Rabaneda EF; Montes García S; Atienza-Mateo B; Calvo-Río V; Corrales Selaya C; Lorenzo Martín JA; Díez Álvarez E | Published 2025 |
    Other Authors: “…Calvo-Río V…”

Search Tools: